Freedom Leaf Inc. (OTCMKTS:FRLF) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Freedom Leaf Inc. (OTCMKTS:FRLF) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Story continues below

On October 30, 2017, Paul Pelosi Jr. was appointed as Chairman of the Board of Directors of Freedom Leaf Inc. (the “Company”).

Mr. Pelosi, age 48, has many years’ experience advising emerging companies in the areas of corporate governance, business development, sustainability and public policy. Since December of 2015, Mr. Pelosi has been the Executive Director of the Corporate Governance Initiative, an organization committed to assisting organizations to adhere to a system of guidelines, practices, and procedures by which a company is directed, and since February of 2015, Mr. Pelosi has been a Senior Representative of National Strategies, LLC, state and local government consulting firm that assists organizations to generate revenue and growth, solve problems and create opportunities. Since 2002, Mr. Pelosi has been a Real Estate Broker of Sinclair, a real estate brokerage firm in the San Francisco Bay Area, and prior to 2011, Mr. Pelosi enjoyed a varied career working with or for a number of financial institutions, public and private corporations, and government commissions. Mr. Pelosi graduated Cum Laude from Georgetown University with a Bachelor of Arts in History in 1991, and a JD/MBA with an emphasis in International Business in 1995. In 1991, Mr. Pelosi was a Gillette All Star Athlete in Track, and he received the Georgetown International Human Rights Award in 1994. Mr. Pelosi is currently a director of Targeted Medical Pharma, Inc. (symbol “TRGM”).

In consideration of Mr. Pelosi’s appointment as a director and as Chairman of the Board, and for his services as such through October 31, 2018, the Company has agreed to issue Mr. Pelosi (i) 1,666,667 shares of the Company’s common stock, and (ii) options to purchase 1,250,000 shares of the Company’s common stock at $0.04/share, exercisable for 18 months. There is no written agreement regarding Mr. Pelosi’s appointment.


About Freedom Leaf Inc. (OTCMKTS:FRLF)

Freedom Leaf, Inc. (Freedom Leaf) is focused on being the national and international news source for the Cannabis/Industrial Hemp industry. The Company, through its online and print media channels, is engaged in dissemination of current legislation and legal news, arts and entertainment. The Company provides advertisements in publications, both print and online, in the cannabis/hemp marketplace. It provides consulting services to companies who are in its industry. It contracts with companies to brand, market and sell their products and/or services. It sells licenses, both domestic and foreign, for the use of the Freedom Leaf brand that includes its products and services. The Company also incubates other companies in the cannabis industry. The Company’s magazine, The Good News in Marijuana Reform, reports on arts, fashion and lifestyle, all of the elements of the burgeoning cannabis movements.

An ad to help with our costs